Evotec SE
Evotec SE (EVOTF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · EVOTF · as of Jun 8, 2026
Key Statistics
Explore Evotec SE Data
evotf stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 6 · Buy rate: 50.0%
Competitors & Peers
evotf competitorsEVOTF
BIOGY
CHIZF
CMOPF
GNMLF
KSPHFStock Performance
Full HistoryAbout Evotec SE
Evotec SE serves as a prominent global partner, offering comprehensive drug discovery and development services to both the pharmaceutical and biotechnology sectors worldwide. The company is actively i…
what is evotec se · evotf stock overview · evotec se company profile · who is evotec se ceo · evotf OTC · evotec se headquarters · evotec se business segments
About Stock Overview & Key Data
Evotec SE (EVOTF) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Oct 7, 2009. As of the latest trading session, EVOTF stock price is $6.69, with a market capitalization of $1.2B. The stock has returned -19.11% over the past 12 months and -16.48% year-to-date.
According to 6 Wall Street analysts, the consensus rating for Evotec SE stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Evotec SE reported revenue of $788.1M and net income of -$103.5M. For detailed data — including Evotec SE revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Evotec SE (EVOTF) stock price is $6.69. The stock is traded on OTC under the ticker symbol EVOTF. The 52-week range is $4.72 – $8.58.